慢性病毒感染中的状细胞疗法:当前的应用,挑战和未来的前景
Mirsaeed Abdollahi1,2, Reyhaneh Rasizadeh1,3,4, Narges Eslami5,6
1Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
概括
树突细胞 (DC) 疗法在治疗慢性病毒感染如艾滋病毒,HBV和HCV方面表现有前途. 优化基于DC的疫苗可能会导致对这些持久病毒的长期免疫力.
科学领域:
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 树突细胞 (DCs) 是重要的免疫调节器.
- 电流疗法是病毒感染的有希望的免疫疗法.
- 慢性病毒感染,如HIV,HBV和HCV,对健康构成重大挑战.
研究的目的:
- 审查基于树突细胞 (DC) 的疫苗在治疗慢性病毒感染方面的潜力.
- 探索病毒性疾病DC疗法的进展和挑战.
- 突出DC洞察力如何改善疫苗设计以获得长期免疫力.
主要方法:
- 对DC疗法和病毒感染研究的文献综述.
- 分析DC在免疫反应调节中的作用.
- 检查基于DC的疫苗开发中的临床进展和挑战.
主要成果:
- 电流疗法在对抗病毒感染方面取得了明显的进展.
- 基于DC的疫苗有可能产生长期的免疫力.
- 优化DC疗法需要解决特定的挑战.
结论:
- 基于直流的疫苗是慢性病毒感染 (HIV,HBV,HCV) 的可行策略.
- 需要进一步的研究来克服挑战并优化DC疗法.
- 利用DC可以导致针对持续的病毒威胁的更有效的疫苗.
更多相关视频
10:24Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
12.8K
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
3.9K
相关概念视频
Microorganisms in Medicine and Therapeutics
922
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
922
Immune Response Against Viral Pathogens
1.7K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.7K
Cytotoxic T Cells-mediated Immune Response
6.4K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.4K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
